These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 76201)

  • 41. Hyperosmolar nonketotic syndrome and steroid diabetes. Occurrence after renal transplantation.
    Woods JE; Zincke H; Palumbo PJ; Johnson WJ; Anderson CF; Frohnert PP; Service FJ
    JAMA; 1975 Mar; 231(12):1261-3. PubMed ID: 1090764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Long-term clinical application of wearable artificial endocrine pancreas].
    Sakakida M; Nishida K; Shimoda S; Matsuo Y; Araki E; Shichiri M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():613-9. PubMed ID: 12387059
    [No Abstract]   [Full Text] [Related]  

  • 43. Application of an artificial endocrine pancreas in the management of the diabetic surgical patient.
    Kerner W; Beischer W; Herfarth C; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):159-61. PubMed ID: 395073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
    Altomare E; Moulin JP; Tavares S; Bourelly N; Lassmann V; Vague P
    Horm Metab Res Suppl; 1979; (8):110-5. PubMed ID: 395065
    [No Abstract]   [Full Text] [Related]  

  • 45. [Improved control of diabetes by serial measurements of ketone bodies and blood sugar].
    Kågedal B; Rooth G
    Nord Med; 1969 Sep; 82(37):1125-9. PubMed ID: 5354521
    [No Abstract]   [Full Text] [Related]  

  • 46. Self glucose monitoring: a comparison of the Glucometer, Glucoscan, and Hypocount B.
    Nelson JD; Woelk MA; Sheps S
    Diabetes Care; 1983; 6(3):262-7. PubMed ID: 6347579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Results with combined kidney and paratopic segmental-pancreas transplantation.
    Brons IG; Calne RY; Jamieson NV; Rolles K; Williams PF; Evans DB
    Diabetes; 1989 Jan; 38 Suppl 1():18-20. PubMed ID: 2642845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.
    Kropff J; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S253-63. PubMed ID: 26784131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of an artificial beta cell in surgery.
    Horwitz DL; Schwartz SS
    Horm Metab Res Suppl; 1979; (8):156-8. PubMed ID: 395072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 10th International conference on advanced technologies & treatments for diabetes.
    Gao HX; Regier EE; Close KL
    J Diabetes; 2016 Jul; 8(4):455-9. PubMed ID: 27100744
    [No Abstract]   [Full Text] [Related]  

  • 51. The use of the artificial pancreas in uremic diabetic patients.
    Slama G; Klein JC; Delage A; Rottembourg J; Marouani A; Jacobs C
    Horm Metab Res Suppl; 1979; (8):178-83. PubMed ID: 395076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Home monitoring of blood-glucose. Method for improving diabetic control.
    Sönksen PH; Judd SL; Lowy C
    Lancet; 1978 Apr; 1(8067):729-32. PubMed ID: 76745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How to monitor blood glucose.
    Dunning T
    Nurs Stand; 2016 Jan; 30(22):36-9. PubMed ID: 26967884
    [No Abstract]   [Full Text] [Related]  

  • 54. Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring.
    Kovatchev BP; Patek SD; Ortiz EA; Breton MD
    Diabetes Technol Ther; 2015 Mar; 17(3):177-86. PubMed ID: 25436913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical value of hemoglobin A1 determination in the control of diabetes].
    Malczewski B; Piniewska-Hułas M; Stryjek-Kamińska D
    Pol Arch Med Wewn; 1980 Nov; 64(5):413-9. PubMed ID: 7012800
    [No Abstract]   [Full Text] [Related]  

  • 56. Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery.
    Klonoff DC
    Pediatr Endocrinol Rev; 2003 Dec; 1(2):94-100. PubMed ID: 16437014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Formal recommendations by the experts. Glycemic control in intensive care unit and during anaesthesia. Société française d'anesthésie et de réanimation. Société de réanimation de langue française].
    ;
    Ann Fr Anesth Reanim; 2009 Apr; 28(4):410-5. PubMed ID: 19328645
    [No Abstract]   [Full Text] [Related]  

  • 58. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy.
    Rizza RA; Gerich JE; Haymond MW; Westland RE; Hall LD; Clemens AH; Service FJ
    N Engl J Med; 1980 Dec; 303(23):1313-8. PubMed ID: 7001229
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Institutional glucometrics to determine glucose control as practiced by general medicine wards.
    Buchs AE; Rapoport MJ
    Isr Med Assoc J; 2010 Aug; 12(8):463-7. PubMed ID: 21337813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Telemetry glucose monitoring device with needle-type glucose sensor: a useful tool for blood glucose monitoring in diabetic individuals.
    Shichiri M; Asakawa N; Yamasaki Y; Kawamori R; Abe H
    Diabetes Care; 1986; 9(3):298-301. PubMed ID: 3731995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.